We pride ourselves in offering our customers an exclusive first-to-launch portfolio of innovative new products.

We also have an unrivalled record of switching prescription products to make them available over-the-counter.

At Perrigo we are committed to providing a regular flow of OTC healthcare products to support the business development aspirations of our customers.

With ongoing investment in product development and a dedicated team tasked to continually develop new products, Perrigo ensures innovation which:-

• Helps grow the OTC markets
• Offsets competitor threats for our Partners
• Produces line extensions and improves healthcare

Our recent licences include:
• Nicotine Lozenges 2 mg & 4 mg
• Ibuprofen Lysine Tablets 342 mg
• Phenylephrine Capsules 12.2 mg
• Max Strength Day & Night Cold & Flu Capsules